{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-004800","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.418235+00:00","generated_at":"2026-05-31T21:08:32.708122+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Phio Pharmaceuticals raises $3.1M via warrant exercise at $5.45/share; issues new warrants","bullets":["Gross proceeds ~$3.1M from cash exercise of 545,286 existing warrants at reduced price of $5.45/share (original range $324-$9.72).","Holders pay additional $0.125 per new warrant for aggregate $136,321; total gross proceeds include this amount.","New Series C (583,098 shares, 5.5-yr term) and Series D (507,474 shares, 18-mo term) warrants issued, exercise price $5.45.","H.C. Wainwright acts as exclusive placement agent; receives 7.5% cash fee, $35k non-accountable expenses, and 40,896 warrants.","Net proceeds to be used for working capital and general corporate purposes; offering closed July 12, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-004800","json":"https://secwatch.observer/filing/0001683168-24-004800.json","markdown":"https://secwatch.observer/filing/0001683168-24-004800.md","text":"https://secwatch.observer/filing/0001683168-24-004800.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824004800/0001683168-24-004800-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824004800/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:08:32.708122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}